Interestingly, the DNAJC16 gene is one of the chaperone families HSP40, which regulates AR and mediating sensitivity to chaperone inhibitors to aid in identifying new drug targets for efficacy in castration-resistant prostate cancer [113]. This evidence concerns the gene DNAJC16 and Familial prostate cancer.